Cidara Therapeutics, Inc.
(NASDAQ : CDTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICLRICON plc -0.13%183.782.7%$103.29m
ARGXargenx SE -1.26%353.050.0%$75.94m
VRXValeant Pharmaceuticals International, Inc. -0.72%6.9014.1%$40.60m
BRBRBellRing Brands, Inc. 1.10%20.630.0%$19.75m
RVMDRevolution Medicines, Inc. 0.87%19.720.0%$18.36m
BGXXBright Green Corp. -9.24%1.080.0%$5.91m
USNAUSANA Health Sciences, Inc. -1.41%56.054.2%$3.67m
ANIKAnika Therapeutics, Inc. 1.67%23.809.7%$2.13m
MTPMidatech Pharma Plc -2.68%1.870.0%$0.43m
IBIOiBio, Inc. -5.21%0.170.2%$0.43m
ENVBEnveric Biosciences, Inc. -2.09%4.220.0%$0.38m
FLGCFlora Growth Corp. 3.01%0.710.0%$0.32m
NATRNature's Sunshine Products, Inc. -0.84%8.240.4%$0.32m
BPTSBiophytis SA 0.00%0.630.0%$0.29m
GHSIGuardion Health Sciences, Inc. 0.36%0.140.0%$0.21m

Company Profile

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. Its product pipeline includes Rezafungin and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.